What is a Named Patient Program?
A Named Patient Program (NPP) allows healthcare providers to access medicines that are not yet approved or licensed in their country for individual patients with specific medical needs. This is often used in situations where no suitable licensed alternative is available, and the patient’s condition requires a treatment that is either:
Still in clinical development.
Approved in another country but not yet available locally.
Unavailable due to regulatory or market limitations.
Through a Named Patient Program, doctors can request access to these medicines on behalf of a patient, providing them with potentially life-saving or life-enhancing treatments that would otherwise be inaccessible.
Unipharma supports Named Patient Programs by helping healthcare providers navigate regulatory requirements, ensuring the safe and timely supply of unlicensed medicines to patients in need.